がん治療による心臓代謝再プログラム:心臓腫瘍学の新たな領域
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
PubMedで要約を見る
まとめ
この要約は機械生成です。癌の治療は心臓の代謝を変化させ 脂肪を燃やす細胞から 糖分に頼る細胞へと変えて 心臓を害します このレビューはこれらの変化を詳細に説明し,よりよい患者の結果のためにパーソナライズされたモニタリングを提案しています.
科学分野
- 心臓病科
- 腫瘍学
- 代謝に関する研究
背景
- 心臓の毒性は 癌の治療における懸念事項であり 患者の生存と生活の質に影響を及ぼしています
- 化学療法,標的療法,免疫療法など がん治療は心臓機能障害を引き起こす可能性があります.
- 癌治療中の心臓細胞の代謝変化を理解することは,副作用を軽減するために極めて重要です.
研究 の 目的
- 癌治療によって引き起こされる心臓の代謝再プログラムメカニズムを体系的に検討する.
- 心臓の細胞代謝に対する様々な癌療法の影響を強調する.
- 心臓毒性の早期発見と管理のための戦略を議論する.
主な方法
- 癌治療による心臓毒性に関する現在の文献の体系的なレビュー.
- 化学療法,標的療法,免疫療法による代謝経路の分析
- 心臓細胞における"逆ワーバーグ効果"の役割の探求.
主要な成果
- ガン治療は脂肪酸の酸化から糖分解への心臓代謝の変化を促します
- 脂質代謝の異常,酸化ストレス,炎症は心臓の機能障害に寄与する.
- "逆ワーブルグ効果"は 薬物によるストレスに対する心臓細胞の反応に 役割を果たします
結論
- 人口特有の心臓の耐性 (例えば,子供や高齢者) を考慮して,パーソナライズされた管理戦略が必要である.
- マルチオミックスの統合,ダイナミック・モニタリング,デジタル・ヘルスは 心臓毒性の早期警告システムの可能性を秘めています.
- 基礎研究と臨床実践を統合することは,がん治療の安全性と患者の治療結果を改善するための"予防・モニタリング・治療"システムの開発に不可欠です.
関連する概念動画
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...